No black box warning on record for Levophed(r) Norepinephrine Bitartrate

As of the latest FDA labeling reviewed, Levophed(r) Norepinephrine Bitartrate (LEVOPHED(R) NOREPINEPHRINE BITARTRATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Levophed(r) Norepinephrine Bitartrate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS LEVOPHED should be used with extreme caution in patients receiving monoamine oxidase inhibitors (MAOI) or antidepressants of the triptyline or imipramine types, because severe, prolonged hypertension may result. LEVOPHED Bitartrate Injection contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe a

No black box warning on record for Levophed(r) Norepinephrine Bitartrate

Other warnings & precautions

WARNINGS LEVOPHED should be used with extreme caution in patients receiving monoamine oxidase inhibitors (MAOI) or antidepressants of the triptyline or imipramine types, because severe, prolonged hypertension may result. LEVOPHED Bitartrate Injection contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe a

Levophed(r) Norepinephrine Bitartrate Black Box Warning

No black box warning on record for Levophed(r) Norepinephrine Bitartrate

Other warnings & precautions

Levophed(r) Norepinephrine Bitartrate Black Box Warning

No black box warning on record for Levophed(r) Norepinephrine Bitartrate

Other warnings & precautions